Bifidobacterium animalis spp. lactis

Eamonn Martin Quigley

doi:10.1016/B978-0-12-804024-9.00013-6

Bifidobacterium animalis spp. lactis

Eamonn Martin Quigley

Research output: Chapter in Book/Report/Conference proceeding › Chapter

8 Scopus citations

Abstract

The species Bifidobacterium animalis populates the mammalian colon and grows well in milk; as a consequence, strains from these species have been isolated from milk cultures. Its resistance to acid and oxidative stress renders strains from these species ideally suited to their formulation in fermented milk products. Laboratory studies have identified a number of properties that could be clinically relevant: immune modulation, epithelial adherence, and enhancement of gut barrier function. Two commercially available strains have been studied extensively: B. animalis spp. lactis BB-12 and B. animalis spp. lactis DN-173 010. The latter has been shown to accelerate gut transit in man and to provide symptom relief to individuals with common gastrointestinal symptoms, irritable bowel syndrome and constipation, while the former has shown some promise in boosting the immune response in man.

Original language	English (US)
Title of host publication	The Microbiota in Gastrointestinal Pathophysiology
Subtitle of host publication	Implications for Human Health, Prebiotics, Probiotics, and Dysbiosis
Publisher	Elsevier
Pages	127-130
Number of pages	4
ISBN (Electronic)	9780128040621
ISBN (Print)	9780128040249
DOIs	https://doi.org/10.1016/B978-0-12-804024-9.00013-6
State	Published - Jan 1 2017

Keywords

Bifidobacterium animalis
Bifidobacterium animalis spp. lactis BB-12
Bifidobacterium animalis spp. lactis DN-173 010
Colon transit
Immune response
Irritable bowel syndrome

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/B978-0-12-804024-9.00013-6

Cite this

@inbook{6be562f34e9e49c692027dfc59a0da1a,

title = "Bifidobacterium animalis spp. lactis",

abstract = "The species Bifidobacterium animalis populates the mammalian colon and grows well in milk; as a consequence, strains from these species have been isolated from milk cultures. Its resistance to acid and oxidative stress renders strains from these species ideally suited to their formulation in fermented milk products. Laboratory studies have identified a number of properties that could be clinically relevant: immune modulation, epithelial adherence, and enhancement of gut barrier function. Two commercially available strains have been studied extensively: B. animalis spp. lactis BB-12 and B. animalis spp. lactis DN-173 010. The latter has been shown to accelerate gut transit in man and to provide symptom relief to individuals with common gastrointestinal symptoms, irritable bowel syndrome and constipation, while the former has shown some promise in boosting the immune response in man.",

keywords = "Bifidobacterium animalis, Bifidobacterium animalis spp. lactis BB-12, Bifidobacterium animalis spp. lactis DN-173 010, Colon transit, Immune response, Irritable bowel syndrome",

author = "Quigley, {Eamonn Martin}",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-804024-9.00013-6",

language = "English (US)",

isbn = "9780128040249",

pages = "127--130",

booktitle = "The Microbiota in Gastrointestinal Pathophysiology",

publisher = "Elsevier",

address = "United States",

}

TY - CHAP

T1 - Bifidobacterium animalis spp. lactis

AU - Quigley, Eamonn Martin

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The species Bifidobacterium animalis populates the mammalian colon and grows well in milk; as a consequence, strains from these species have been isolated from milk cultures. Its resistance to acid and oxidative stress renders strains from these species ideally suited to their formulation in fermented milk products. Laboratory studies have identified a number of properties that could be clinically relevant: immune modulation, epithelial adherence, and enhancement of gut barrier function. Two commercially available strains have been studied extensively: B. animalis spp. lactis BB-12 and B. animalis spp. lactis DN-173 010. The latter has been shown to accelerate gut transit in man and to provide symptom relief to individuals with common gastrointestinal symptoms, irritable bowel syndrome and constipation, while the former has shown some promise in boosting the immune response in man.

AB - The species Bifidobacterium animalis populates the mammalian colon and grows well in milk; as a consequence, strains from these species have been isolated from milk cultures. Its resistance to acid and oxidative stress renders strains from these species ideally suited to their formulation in fermented milk products. Laboratory studies have identified a number of properties that could be clinically relevant: immune modulation, epithelial adherence, and enhancement of gut barrier function. Two commercially available strains have been studied extensively: B. animalis spp. lactis BB-12 and B. animalis spp. lactis DN-173 010. The latter has been shown to accelerate gut transit in man and to provide symptom relief to individuals with common gastrointestinal symptoms, irritable bowel syndrome and constipation, while the former has shown some promise in boosting the immune response in man.

KW - Bifidobacterium animalis

KW - Bifidobacterium animalis spp. lactis BB-12

KW - Bifidobacterium animalis spp. lactis DN-173 010

KW - Colon transit

KW - Immune response

KW - Irritable bowel syndrome

UR - http://www.scopus.com/inward/record.url?scp=85027313242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027313242&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-804024-9.00013-6

DO - 10.1016/B978-0-12-804024-9.00013-6

M3 - Chapter

AN - SCOPUS:85027313242

SN - 9780128040249

SP - 127

EP - 130

BT - The Microbiota in Gastrointestinal Pathophysiology

PB - Elsevier

ER -

Bifidobacterium animalis spp. lactis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this